These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 23876322)

  • 1. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Nolte G; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Neuroscience; 2013 Oct; 250():320-32. PubMed ID: 23876322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interhemispheric functional interactions between the subthalamic nuclei of patients with Parkinson's disease.
    Hohlefeld FU; Huchzermeyer C; Huebl J; Schneider GH; Brücke C; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Eur J Neurosci; 2014 Oct; 40(8):3273-83. PubMed ID: 25195608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease.
    Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO
    J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range temporal correlations in the subthalamic nucleus of patients with Parkinson's disease.
    Hohlefeld FU; Huebl J; Huchzermeyer C; Schneider GH; Schönecker T; Kühn AA; Curio G; Nikulin VV
    Eur J Neurosci; 2012 Sep; 36(6):2812-21. PubMed ID: 22985199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease.
    Giannicola G; Marceglia S; Rossi L; Mrakic-Sposta S; Rampini P; Tamma F; Cogiamanian F; Barbieri S; Priori A
    Exp Neurol; 2010 Nov; 226(1):120-7. PubMed ID: 20713047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial extent of β oscillatory activity in and between the subthalamic nucleus and substantia nigra pars reticulata of Parkinson's disease patients.
    Alavi M; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
    Exp Neurol; 2013 Jul; 245():60-71. PubMed ID: 23063495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic local field potential oscillations during ongoing deep brain stimulation in Parkinson's disease.
    Rossi L; Marceglia S; Foffani G; Cogiamanian F; Tamma F; Rampini P; Barbieri S; Bracchi F; Priori A
    Brain Res Bull; 2008 Jul; 76(5):512-21. PubMed ID: 18534260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease.
    Foffani G; Ardolino G; Egidi M; Caputo E; Bossi B; Priori A
    Brain Res Bull; 2006 Mar; 69(2):123-30. PubMed ID: 16533660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease.
    Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Neuroimage; 2013 Mar; 68():203-13. PubMed ID: 23247184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased SMA-M1 coherence in Parkinson's disease - Pathophysiology or compensation?
    Pollok B; Kamp D; Butz M; Wojtecki L; Timmermann L; Südmeyer M; Krause V; Schnitzler A
    Exp Neurol; 2013 Sep; 247():178-81. PubMed ID: 23664959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 300-Hz subthalamic oscillations in Parkinson's disease.
    Foffani G; Priori A; Egidi M; Rampini P; Tamma F; Caputo E; Moxon KA; Cerutti S; Barbieri S
    Brain; 2003 Oct; 126(Pt 10):2153-63. PubMed ID: 12937087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between cortical and subcortical neural dynamics on multiple time scales in Parkinson's disease.
    Hohlefeld FU; Ehlen F; Tiedt HO; Krugel LK; Horn A; Kühn AA; Curio G; Klostermann F; Nikulin VV
    Neuroscience; 2015 Jul; 298():145-60. PubMed ID: 25881724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.
    Giannicola G; Rosa M; Marceglia S; Scelzo E; Rossi L; Servello D; Menghetti C; Pacchetti C; Zangaglia R; Locatelli M; Caputo E; Cogiamanian F; Ardolino G; Barbieri S; Priori A
    Neurosignals; 2013; 21(1-2):89-98. PubMed ID: 22538235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The STN beta-band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation.
    Bronte-Stewart H; Barberini C; Koop MM; Hill BC; Henderson JM; Wingeier B
    Exp Neurol; 2009 Jan; 215(1):20-8. PubMed ID: 18929561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
    Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
    Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct oscillatory STN-cortical loops revealed by simultaneous MEG and local field potential recordings in patients with Parkinson's disease.
    Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
    Neuroimage; 2011 Apr; 55(3):1159-68. PubMed ID: 21122819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia.
    Chung JW; Burciu RG; Ofori E; Coombes SA; Christou EA; Okun MS; Hess CW; Vaillancourt DE
    Neuroimage Clin; 2018; 19():559-571. PubMed ID: 29984164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease.
    Priori A; Foffani G; Pesenti A; Tamma F; Bianchi AM; Pellegrini M; Locatelli M; Moxon KA; Villani RM
    Exp Neurol; 2004 Oct; 189(2):369-79. PubMed ID: 15380487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.